Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT01331967
Eligibility Criteria:
Inclusion Criteria:
* Age: 18 years and above
* Gender eligible for study: both
* Diabetic patients either previously diagnosed or newly found diabetes.
* Fasting blood glucose ≥ 126 mg/dl or PP2 blood glucose ≥ 200 mg/dl for newly found diabetes.
* Patients with significant coronary artery disease (diameter stenosis \> 70%) requiring stent implantation.
* Patients with informed consent.
Exclusion Criteria:
* Diabetic patients with the use of thiazolidinediones
* ACE inhibitor or ARB not allowed during the study period
* Previous history of PCI or bypass surgery
* Patients with any contraindications to the treatment of thiazolidinediones
* Pregnant or lactating patients
* Chronic alcohol or drug abuse
* Hepatic dysfunction
* Renal dysfunction
* Heart failure (EF \< 50%)
* Expected life expectancy of \< 1 year
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01331967
Study Brief:
Protocol Section:
NCT01331967